No Data
No Data
Wolfe Research Initiates Incyte(INCY.US) With Buy Rating, Announces Target Price $84
Incyte Initiated With an Outperform at Wolfe Research
Optimism Around Aquestive As It Moves Forward With Severe Allergy, Baldness Candidate
Is Incyte Stock Underperforming the Nasdaq?
Truist Financial Maintains Incyte(INCY.US) With Hold Rating, Maintains Target Price $74
Incyte Gains 12.7% Year to Date: How Should You Play the Stock?
No Data
No Data